HIV/AIDS Clinical Trials in Chicago

Showing 161-180 of 291 trials

Intervention for Newly Diagnosed Youth With HIV

NCT00510237

This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.

HIV

University of North Carolina, Chapel Hill50 participantsStarted Feb 2007

Miami, Florida, United States • Chicago, Illinois, United States • The Bronx, New York, United States +1 more locations

COMPLETEDPHASE42.2 miles

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

NCT00068809

This study will determine if taking anti-HIV drugs 4 days a week will control HIV-1 viral replication in patients who have already had at least 6 months of documented viral suppression with full-time treatment. If this strategy is shown to be safe in this study, a larger study will be undertaken to determine if the strategy can decrease overall drug exposure and help young people adjust more easily to a chronic medication schedule.

HIV Infections

University of North Carolina, Chapel Hill31 participantsStarted Jul 2003

Los Angeles, California, United States • San Diego, California, United States • Washington D.C., District of Columbia, United States +6 more locations

Intervention for Newly Diagnosed Youth With HIV

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

HIV/AIDS Trials in Other Cities

PHASES: Provision of HIV Treatment at ATN Sites: An Evaluation for Stakeholders

Factors Affecting PrEP Adherence

CDC-ATN Linkage Evaluation

C2P Mobilization Intervention (Pilot)

HIV Treatment-Readiness Measure (HTRM) Validation

Linkage to Care - Part II

Treatment De-Intensification and Residual HIV-1 in Youth

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Correlates of Oral Human Papillomavirus Infection in Adolescents and Young Adults With Behaviorally Acquired HIV

Feasibility of Using a Structured Daily Diary

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Other Conditions in Chicago